Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2017
Association Between Precautionary Behaviors and Breast Cancer-Related Lymphedema in Patients Undergoing Bilateral Surgery
Maria S Asdourian, Meyha N Swaroop, Hoda E Sayegh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2022
Evaluating the treatment of cutaneous adverse events and adherence to National Comprehensive Cancer Network guidelines in patients receiving immune checkpoint inhibitors
Michael S Chang, Ted V Jacoby, Tracey S Otto, et al.
The British Journal of Dermatology
|
March 15, 2022
Association of pre-existing drug allergies with cutaneous immune-related adverse events among patients on immune checkpoint inhibitor therapy
Ted V Jacoby, Tracey S Otto, Maria S Asdourian, et al.
Journal of the American Academy of Dermatology
|
February 3, 2023
Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy
Maria S Asdourian, Ted V Jacoby, Nishi Shah, et al.
Journal of the American Academy of Dermatology
|
June 23, 2022
Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade
Maria S Asdourian, Nishi Shah, Ted V Jacoby, et al.
Journal of the American Academy of Dermatology
|
February 10, 2024
Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort study
Rachel M Reardon, Katherine L Perlman, Maria S Asdourian, et al.
Journal of the American Academy of Dermatology
|
June 20, 2022
Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study
Maria S Asdourian, Ted V Jacoby, Nishi Shah, et al.
Journal of the American Academy of Dermatology
|
September 16, 2022
Dermatology evaluation for cutaneous immune-related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition
Ted V Jacoby, Nishi Shah, Maria S Asdourian, et al.
Journal of the American Academy of Dermatology
|
February 22, 2023
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma
Michael R Stephens, Maria S Asdourian, Ted V Jacoby, et al.
Journal of the American Academy of Dermatology
|
February 22, 2022
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma
Maria S Asdourian, Tracey S Otto, Ted V Jacoby, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2017
Association Between Precautionary Behaviors and Breast Cancer-Related Lymphedema in Patients Undergoing Bilateral Surgery
Maria S Asdourian, Meyha N Swaroop, Hoda E Sayegh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2022
Evaluating the treatment of cutaneous adverse events and adherence to National Comprehensive Cancer Network guidelines in patients receiving immune checkpoint inhibitors
Michael S Chang, Ted V Jacoby, Tracey S Otto, et al.
The British Journal of Dermatology
|
March 15, 2022
Association of pre-existing drug allergies with cutaneous immune-related adverse events among patients on immune checkpoint inhibitor therapy
Ted V Jacoby, Tracey S Otto, Maria S Asdourian, et al.
Journal of the American Academy of Dermatology
|
February 3, 2023
Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy
Maria S Asdourian, Ted V Jacoby, Nishi Shah, et al.
Journal of the American Academy of Dermatology
|
June 23, 2022
Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade
Maria S Asdourian, Nishi Shah, Ted V Jacoby, et al.
Journal of the American Academy of Dermatology
|
February 10, 2024
Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort study
Rachel M Reardon, Katherine L Perlman, Maria S Asdourian, et al.
Journal of the American Academy of Dermatology
|
June 20, 2022
Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study
Maria S Asdourian, Ted V Jacoby, Nishi Shah, et al.
Journal of the American Academy of Dermatology
|
September 16, 2022
Dermatology evaluation for cutaneous immune-related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition
Ted V Jacoby, Nishi Shah, Maria S Asdourian, et al.
Journal of the American Academy of Dermatology
|
February 22, 2023
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma
Michael R Stephens, Maria S Asdourian, Ted V Jacoby, et al.
Journal of the American Academy of Dermatology
|
February 22, 2022
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma
Maria S Asdourian, Tracey S Otto, Ted V Jacoby, et al.
Page
of 3